Intramuscular Vaccine Adjuvants Market Expected to Reach US$ 650.6 Million by 2022
Intramuscular Vaccine Adjuvants Market Market Overview: The global intramuscular vaccine adjuvants market is estimated to be valued at US$ 650.6 million in 2022 and is expected to exhibit a CAGR of 6.7% over the forecast period of 2023-2030, as highlighted in a new report published by Coherent Market Insights. Intramuscular vaccine adjuvants are substances that are added to vaccines to enhance their immune response. These adjuvants help to stimulate a stronger and longer-lasting immune response, resulting in increased efficacy of vaccines. The need for intramuscular vaccine adjuvants arises from the increasing prevalence of infectious diseases and the growing demand for effective and safe vaccines. Market Key Trends: One key trend in the intramuscular vaccine adjuvants market is the increasing adoption of novel adjuvant technologies. Advancements in vaccine technology and immunology have led to the development of innovative adjuvant formulations. These new adjuvants offer improv...